Systemic Prostaglandin E1 to Treat Acute Central Retinal Artery Occlusion

Abstract

Systemic administration of PGE1 for acute CRAO rapidly restores retinal blood flow by its vasodilatory effects, improves VA, is well tolerated with few side effects, and requires no special training.